The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics

Grommé, M., van der Valk, R., Sliedregt, K., Vernie, L., Liskamp, R. , Hämmerling, G., Koopmann, J.-O., Momburg, F. and Neefjes, J. (1997) The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics. European Journal of Immunology, 27(4), pp. 898-904. (doi:10.1002/eji.1830270415)

Full text not currently available from Enlighten.

Abstract

The major histocompatibility complex (MHC)-encoded transporter associated with antigen processing (TAP) translocates peptides from the cytosol into the lumen of the endoplasmic reticulum. This step precedes the binding of peptides to MHC class I molecules and is essential for cell surface expression of the MHC class I/peptide complex. TAP has a broad sequence specificity and a preference for peptides of around 9 amino acids. To synthesize inhibitors for TAP, we studied various alterations of the peptide substrate. The results indicate that TAP is stereospecific and that peptide bonds engineered into isosteric structures can improve translocation of the peptide. Furthermore, TAP is able to translocate peptides with large side chains that correspond to a peptide of ∼ 21 amino acids in extended conformation. Peptides with longer side chains compete for the peptide binding site of TAP but fail to be translocated. Therefore, they represent the first rationally designed inhibitors of TAP.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Liskamp, Professor Robert
Authors: Grommé, M., van der Valk, R., Sliedregt, K., Vernie, L., Liskamp, R., Hämmerling, G., Koopmann, J.-O., Momburg, F., and Neefjes, J.
College/School:College of Science and Engineering > School of Chemistry
Journal Name:European Journal of Immunology
Journal Abbr.:Eur. J. Immunol.
ISSN:0014-2980
ISSN (Online):1521-4141

University Staff: Request a correction | Enlighten Editors: Update this record